Re: (Another) modest proposal

Issue: BCMJ, vol. 54, No. 1, January February 2012, Pages 11-12 Letters
By: Ralph Jones, MD

I read with interest Dr Preshaw’s letter on the InspireHealth breakthrough in breast cancer survival [(Another) modest proposal BCMJ 2011;53:455].

I support his admonition to publish quickly so that our patients, friends, and family members with breast cancer can receive the benefits.
A word of caution, however, delivered by the philosopher George Santayana, whose aphorism “Those who cannot remember the past are condemned to repeat it” might be instructive in this context.

In the late 1980s the NHS funded a trial on complementary therapy de­livered by the Bristol Cancer Help Centre.[1] This trial was to be the evidence to publicly fund a network of complementary therapy centres across the UK.

The trial results were unexpected. Those in the complementary therapy group actually did worse than controls. The penny-pinching NHS un­graciously withdrew public funding.

The trial did not deal with any benefits on the quality of life for trial participants (there was, however, a suggestion of a deleterious effect on quality of life with the strict regime allowing focus only on cancer and survival).

It is both exciting and somewhat puzzling to read that BC research is showing a positive benefit on mortality in breast cancer sufferers. I too look forward to the published results.

In case these are not quite as ex­pected, I hope the government will be as cautious with taxpayers’ dollars as the NHS eventually was. However, I do hope we continue to support the holistic treatment of all cancer pa­tients, including complementary therapies where a benefit on the quality of life—if not the length of life—can be shown.
—Ralph Jones, MD
Chilliwack

References

1. Bagenal FS, Easton DF, Harris E, et al. Survival of patients with breast cancer attending Bristol Cancer Help Centre. Lancet 1990;336:606-610.

Ralph Jones, MD. Re: (Another) modest proposal. BCMJ, Vol. 54, No. 1, January, February, 2012, Page(s) 11-12 - Letters.


Above is the information needed to cite this article in your paper or presentation. The International Committee of Medical Journal Editors (ICMJE) recommends the following citation style, which is the now nearly universally accepted citation style for scientific papers:
Halpern SD, Ubel PA, Caplan AL, Marion DW, Palmer AM, Schiding JK, et al. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.

About the ICMJE and citation styles

The ICMJE is small group of editors of general medical journals who first met informally in Vancouver, British Columbia, in 1978 to establish guidelines for the format of manuscripts submitted to their journals. The group became known as the Vancouver Group. Its requirements for manuscripts, including formats for bibliographic references developed by the U.S. National Library of Medicine (NLM), were first published in 1979. The Vancouver Group expanded and evolved into the International Committee of Medical Journal Editors (ICMJE), which meets annually. The ICMJE created the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals to help authors and editors create and distribute accurate, clear, easily accessible reports of biomedical studies.

An alternate version of ICMJE style is to additionally list the month an issue number, but since most journals use continuous pagination, the shorter form provides sufficient information to locate the reference. The NLM now lists all authors.

BCMJ standard citation style is a slight modification of the ICMJE/NLM style, as follows:

  • Only the first three authors are listed, followed by "et al."
  • There is no period after the journal name.
  • Page numbers are not abbreviated.


For more information on the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, visit www.icmje.org

BCMJ Guidelines for Authors

Leave a Reply